Schedule 2 Directions for securing compliance with the first, second and third Directives
- Traceability and coding system
- Reporting obligations
- Serious adverse events and serious adverse reactions
- Third party agreements and termination of licensed activities
- Procurement and use of tissue or cells
- Selection criteria and laboratory tests required for donors of tissues and cells
- Donation and procurement procedures and reception at the tissue establishment
- Requirements for holding a licence under Schedule 1
- Requirements for holding a licence under Schedule 1 for tissue and cell preparation processes